Quest Diagnostics Inc.
Thesis
Quest Diagnostics was a simple business that faced challenges due to changes in Medicare and HMO pricing, which significantly impacted their earnings. However, after thorough research and observing the stabilization of pricing, the company demonstrated a clear strategy to improve margins, making it an attractive investment opportunity.
Did it work?
The long thesis on Quest Diagnostics played out decisively: the stock returned +1634% since the pitch, a roughly 17x gain that far exceeds any reasonable hurdle for the stated thesis of pricing stabilization and margin improvement. While the exact time elapsed is unknown, a return of this magnitude indicates the anticipated earnings recovery and margin expansion were realized rather than being modest interim noise. The direction of the return aligns squarely with the long positioning.